Cargando…

Design, Radiosynthesis and Preliminary Biological Evaluation in Mice of a Brain-Penetrant (18)F-Labelled σ(2) Receptor Ligand

The σ(2) receptor (transmembrane protein 97), which is involved in cholesterol homeostasis, is of high relevance for neoplastic processes. The upregulated expression of σ(2) receptors in cancer cells and tissue in combination with the antiproliferative potency of σ(2) receptor ligands motivates the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moldovan, Rareş-Petru, Gündel, Daniel, Teodoro, Rodrigo, Ludwig, Friedrich-Alexander, Fischer, Steffen, Toussaint, Magali, Schepmann, Dirk, Wünsch, Bernhard, Brust, Peter, Deuther-Conrad, Winnie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196714/ https://www.ncbi.nlm.nih.gov/pubmed/34064122 http://dx.doi.org/10.3390/ijms22115447

Ejemplares similares

Development of [(18)F]LU14 for PET Imaging of Cannabinoid Receptor Type 2 in the Brain
por: Teodoro, Rodrigo, et al.
Publicado: (2021)

Preclinical Evaluation of [(18)F]FACH in Healthy Mice and Piglets: An (18)F-Labeled Ligand for Imaging of Monocarboxylate Transporters with PET
por: Gündel, Daniel, et al.
Publicado: (2021)

Asymmetric Synthesis of Spirocyclic 2-Benzopyrans for Positron Emission Tomography of σ(1) Receptors in the Brain
por: Holl, Katharina, et al.
Publicado: (2014)

Development of Novel Analogs of the Monocarboxylate Transporter Ligand FACH and Biological Validation of One Potential Radiotracer for Positron Emission Tomography (PET) Imaging
por: Sadeghzadeh, Masoud, et al.
Publicado: (2020)

Radiofluorination and biological evaluation of N-aryl-oxadiazolyl-propionamides as potential radioligands for PET imaging of cannabinoid CB(2) receptors
por: Teodoro, Rodrigo, et al.
Publicado: (2013)

Synthesis and Preliminary Biological Evaluation of Indol-3-yl-oxoacetamides as Potent Cannabinoid Receptor Type 2 Ligands
por: Moldovan, Rareş-Petru, et al.
Publicado: (2017)

Development of a Radiofluorinated Adenosine A(2B) Receptor Antagonist as Potential Ligand for PET Imaging
por: Lindemann, Marcel, et al.
Publicado: (2020)

Development of cannabinoid receptor (CB 2 R) ligands for application in PET studies - where to attach the radiolabel?
por: Günther, Robert, et al.
Publicado: (2014)

Radiosynthesis and Biological Investigation of a Novel Fluorine-18 Labeled Benzoimidazotriazine-Based Radioligand for the Imaging of Phosphodiesterase 2A with Positron Emission Tomography
por: Ritawidya, Rien, et al.
Publicado: (2019)

Synthesis, Structure–Activity Relationships, Radiofluorination, and Biological Evaluation of [(18)F]RM365, a Novel Radioligand for Imaging the Human Cannabinoid Receptor Type 2 (CB2R) in the Brain with PET
por: Teodoro, Rodrigo, et al.
Publicado: (2023)

Synthesis and Biological Evaluation of a Novel (18)F-Labeled Radiotracer for PET Imaging of the Adenosine A(2A) Receptor
por: Lai, Thu Hang, et al.
Publicado: (2021)

Improved in vivo PET imaging of the adenosine A(2A) receptor in the brain using [(18)F]FLUDA, a deuterated radiotracer with high metabolic stability
por: Lai, Thu Hang, et al.
Publicado: (2021)

A 3D-QSAR model for cannabinoid receptor (CB2) ligands derived from aligned pharmacophors
por: Günther, Robert, et al.
Publicado: (2013)

Preclinical Incorporation Dosimetry of [(18)F]FACH—A Novel (18)F-Labeled MCT1/MCT4 Lactate Transporter Inhibitor for Imaging Cancer Metabolism with PET
por: Sattler, Bernhard, et al.
Publicado: (2020)

Quantitation of the A(2A) Adenosine Receptor Density in the Striatum of Mice and Pigs with [(18)F]FLUDA by Positron Emission Tomography
por: Gündel, Daniel, et al.
Publicado: (2022)

Development of (18)F-Labeled Radiotracers for PET Imaging of the Adenosine A(2A) Receptor: Synthesis, Radiolabeling and Preliminary Biological Evaluation
por: Lai, Thu Hang, et al.
Publicado: (2021)

Radiosynthesis and Preclinical Evaluation of an (18)F-Labeled Triazolopyridopyrazine-Based Inhibitor for Neuroimaging of the Phosphodiesterase 2A (PDE2A)
por: Wenzel, Barbara, et al.
Publicado: (2022)

Non-Invasive Assessment of Locally Overexpressed Human Adenosine 2A Receptors in the Heart of Transgenic Mice
por: Gündel, Daniel, et al.
Publicado: (2022)

One-step radiosynthesis of the MCTs imaging agent [(18)F]FACH by aliphatic (18)F-labelling of a methylsulfonate precursor containing an unprotected carboxylic acid group
por: Sadeghzadeh, Masoud, et al.
Publicado: (2019)

In vitro and in vivo Human Metabolism of (S)-[(18)F]Fluspidine – A Radioligand for Imaging σ(1) Receptors With Positron Emission Tomography (PET)
por: Ludwig, Friedrich-Alexander, et al.
Publicado: (2019)

Synthesis of σ Receptor Ligands with a Spirocyclic System Connected with a Tetrahydroisoquinoline Moiety via Different Linkers
por: Bergkemper, Melanie, et al.
Publicado: (2021)

PET Imaging of the Adenosine A(2A) Receptor in the Rotenone-Based Mouse Model of Parkinson’s Disease with [(18)F]FESCH Synthesized by a Simplified Two-Step One-Pot Radiolabeling Strategy
por: Schröder, Susann, et al.
Publicado: (2020)

Sigma-1 Receptor Positron Emission Tomography: A New Molecular Imaging Approach Using (S)-(−)-[(18)F]Fluspidine in Glioblastoma
por: Toussaint, Magali, et al.
Publicado: (2020)

Development of Fluorinated Non-Peptidic Ghrelin Receptor Ligands for Potential Use in Molecular Imaging
por: Moldovan, Rareş-Petru, et al.
Publicado: (2017)

Radiosynthesis and Radiotracer Properties of a 7-(2-[(18)F]Fluoroethoxy)-6-methoxypyrrolidinylquinazoline for Imaging of Phosphodiesterase 10A with PET
por: Funke, Uta, et al.
Publicado: (2012)

Development and Biological Evaluation of the First Highly Potent and Specific Benzamide-Based Radiotracer [(18)F]BA3 for Imaging of Histone Deacetylases 1 and 2 in Brain
por: Clauß, Oliver, et al.
Publicado: (2022)

Evaluation of the Enantiomer Specific Biokinetics and Radiation Doses of [(18)F]Fluspidine—A New Tracer in Clinical Translation for Imaging of σ(1) Receptors
por: Kranz, Mathias, et al.
Publicado: (2016)

Propellanes as Rigid Scaffolds for the Stereodefined Attachment of σ-Pharmacophoric Structural Elements to Achieve σ Affinity
por: Torres-Gómez, Héctor, et al.
Publicado: (2021)

Synthesis of Aminoethyl‐Substituted Piperidine Derivatives as σ(1) Receptor Ligands with Antiproliferative Properties
por: Holtschulte, Catharina, et al.
Publicado: (2022)

Exploring the Metabolism of (+)-[(18)F]Flubatine In Vitro and In Vivo: LC-MS/MS Aided Identification of Radiometabolites in a Clinical PET Study †
por: Ludwig, Friedrich-Alexander, et al.
Publicado: (2018)

Discovery and development of brain-penetrant (18)F-labeled radioligands for neuroimaging of the sigma-2 receptors
por: Zhang, Ying, et al.
Publicado: (2022)

Development of a New Radiofluorinated Quinoline Analog for PET Imaging of Phosphodiesterase 5 (PDE5) in Brain
por: Liu, Jianrong, et al.
Publicado: (2016)

Cannabinoid receptor type 2 (CB2)-selective N-aryl-oxadiazolyl-propionamides: synthesis, radiolabelling, molecular modelling and biological evaluation
por: Rühl, Thomas, et al.
Publicado: (2012)

Novel Radioligands for Cyclic Nucleotide Phosphodiesterase Imaging with Positron Emission Tomography: An Update on Developments Since 2012
por: Schröder, Susann, et al.
Publicado: (2016)

Amphiphilic Anionic Oligomer-Stabilized Calcium Phosphate Nanoparticles with Prospects in siRNA Delivery via Convection-Enhanced Delivery
por: Mitrach, Franziska, et al.
Publicado: (2022)

Synthesis, (18)F-Radiolabelling and Biological Characterization of Novel Fluoroalkylated Triazine Derivatives for in Vivo Imaging of Phosphodiesterase 2A in Brain via Positron Emission Tomography
por: Schröder, Susann, et al.
Publicado: (2015)

Radiation dosimetry of the α(4)β(2) nicotinic receptor ligand (+)-[(18)F]flubatine, comparing preclinical PET/MRI and PET/CT to first-in-human PET/CT results
por: Kranz, Mathias, et al.
Publicado: (2016)

Investigation of an (18)F-labelled Imidazopyridotriazine for Molecular Imaging of Cyclic Nucleotide Phosphodiesterase 2A
por: Schröder, Susann, et al.
Publicado: (2018)

Synthesis of Novel Fluorinated Xanthine Derivatives with High Adenosine A(2B) Receptor Binding Affinity
por: Lindemann, Marcel, et al.
Publicado: (2021)

(+)-[(18)F]Flubatine as a novel α4β2 nicotinic acetylcholine receptor PET ligand—results of the first-in-human brain imaging application in patients with β-amyloid PET-confirmed Alzheimer’s disease and healthy controls
por: Tiepolt, Solveig, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_i3adv1rdp04a2orqgdubf5d8ia